Table 3 |
|||||
|
Frequency of prescription of complete therapeutic regimen or sub-therapeutic regimen of chloroquine over a twenty-year period at a private hospital in Ibadan, south-west Nigeria |
|||||
|
Full course regimen |
Sub-therapeutic regimen |
||||
|
|
|||||
|
YEAR |
N |
F |
N |
F |
|
|
|
|||||
|
1983 (N = 289) |
269 |
93.1% |
20 |
6.9% |
Pre-resistance phase |
|
|
|||||
|
1985 (N = 298) |
293 |
98.3% |
5 |
1.7% |
|
|
|
|||||
|
1987 (N = 295) |
284 |
96.3% |
11 |
3.7% |
Phase of emerging resistance |
|
|
|||||
|
1989 (N = 220) |
214 |
97.3% |
6 |
2.7% |
|
|
|
|||||
|
1992 (N = 258) |
202 |
78.3% |
56 |
21.7% |
|
|
|
|||||
|
1995 (N = 243) |
177 |
72.8% |
66 |
27.2% |
Phase of resistance dissemination |
|
|
|||||
|
1997 (N = 241) |
136 |
56.4% |
105 |
43.6% |
|
|
|
|||||
|
N = No. of prescriptions evaluated F = Frequency of prescription |
|||||
|
Gbotosho et al. Malaria Journal 2009 8:313 doi:10.1186/1475-2875-8-313 |
|||||